Xenon Pharmaceuticals XENE
$ 38.55
-0.9%
Quarterly report 2024-Q3
added 11-12-2024
Xenon Pharmaceuticals Cash and Cash Equivalents 2011-2024 | XENE
Annual Cash and Cash Equivalents Xenon Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
149 M | 57.2 M | 176 M | 45 M | 24.8 M | 67.8 M | 20.5 M | 17.1 M | 58.7 M | 72 M | 38 M | 60.2 M | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
176 M | 17.1 M | 65.5 M |
Quarterly Cash and Cash Equivalents Xenon Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
87.6 M | 137 M | 58.9 M | 149 M | 99.6 M | 64.6 M | 69.5 M | 57.2 M | 103 M | 370 M | 117 M | 176 M | 87.8 M | 82.9 M | 88 M | 45 M | 45 M | 45 M | 45 M | 24.8 M | 24.8 M | 24.8 M | 24.8 M | 67.8 M | 67.8 M | 67.8 M | 67.8 M | 20.5 M | 20.5 M | 20.5 M | 20.5 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 58.7 M | 58.7 M | 58.7 M | 58.7 M | 72 M | 72 M | 72 M | 72 M | 38 M | 38 M | - | - | 60.2 M | - | - | - | 13.9 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
370 M | 13.9 M | 66.4 M |